Veradermics, Incorporated (MANE)
NYSE: MANE · Real-Time Price · USD
51.32
+2.76 (5.68%)
At close: Mar 9, 2026, 4:00 PM EDT
51.32
0.00 (0.00%)
After-hours: Mar 9, 2026, 6:30 PM EDT
Veradermics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Net Income | -53.81 | -26.49 | -16.49 |
| Stock-Based Compensation | 0.56 | 0.25 | 0.21 |
| Other Operating Activities | 2.5 | 1.82 | 1.85 |
| Change in Accounts Payable | 0.78 | 0.65 | 1.35 |
| Change in Other Net Operating Assets | -1.22 | 0.09 | -0.43 |
| Operating Cash Flow | -51.61 | -23.69 | -13.51 |
| Long-Term Debt Issued | - | 8.51 | - |
| Long-Term Debt Repaid | - | -0.85 | - |
| Net Debt Issued (Repaid) | -2.51 | 7.66 | - |
| Other Financing Activities | -0.29 | -0.28 | -0.04 |
| Financing Cash Flow | 59.94 | 60.48 | 13.9 |
| Net Cash Flow | -0.75 | 36.79 | 0.39 |
| Cash Interest Paid | 0.1 | 0.1 | - |
| Levered Free Cash Flow | - | -16.37 | - |
| Unlevered Free Cash Flow | - | -16.01 | - |
| Change in Working Capital | -0.44 | 0.73 | 0.92 |
Source: S&P Capital IQ. Standard template.
Financial Sources.